Navigation Links
Birner Dental Management Services, Inc. Announces Earnings for Year End and Fourth Quarter 2008
Date:3/26/2009

DENVER, March 26 /PRNewswire-FirstCall/ -- Birner Dental Management Services, Inc. (Nasdaq: BDMS), operators of PERFECT TEETH dental practices, announced results for the year ended December 31, 2008. Total dental group practice revenue decreased $371,000, or .6%, to $59.0 million. Net revenue decreased $760,000, or 2.2%, to $34.5 million.

The Company's earnings before interest, taxes, depreciation, amortization and non-cash expense associated with stock-based compensation ("Adjusted EBITDA") decreased $1.1 million, or 13.7%, to $6.8 million from $7.8 million for the year ended December 31, 2007.

Net income for the year ended December 31, 2008 decreased $645,000, or 26.5% to $1.8 million. Earnings per share decreased 20.4% to $.86 for the year ended December 31, 2008 compared to $1.08 for the year ended December 31, 2007.

For the quarter ended December 31, 2008, total dental group practice revenue increased $41,000 or .3%, to $13.9 million. Net revenue decreased $150,000, or 1.8%, to $8.0 million. The Company's Adjusted EBITDA decreased $152,000, or 9.1%, to $1.5 million for the quarter ended December 31, 2008 compared to $1.7 million for the quarter ended December 31, 2007.

Net income for the quarter ended December 31, 2008 decreased $85,000, or 20.9% to $323,000. Earnings per share decreased 9.5% to $.17 for the quarter ended December 31, 2008 compared to $.19 for the quarter ended December 31, 2007.

The decrease in net revenue of $760,000 for the year ended December 31, 2008 consisted of a decrease in net revenue from general dentistry of $1.3 million partly offset by an increase in net revenue from specialty dentistry of $536,000. The decrease in net revenue of $150,000 for the quarter ended December 31, 2008 consisted of a decrease in net reven
'/>"/>

SOURCE Birner Dental Management Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Birner Dental Management Services, Inc. Schedules Earnings Call to Discuss Year End and Fourth Quarter 2008 Results
2. Birner Dental Management Services, Inc. Declares $.17 Quarterly Dividend
3. Birner Dental Management Services, Inc. Declares $.17 Quarterly Dividend
4. Birner Dental Management Services, Inc. Schedules Earnings Call to Discuss Third Quarter 2008 Results
5. Birner Dental Management Services, Inc. Schedules Earnings Call to Discuss Second Quarter 2008 Results
6. Birner Dental Management Services, Inc. Declares $.17 Quarterly Dividend
7. Birner Dental Management Services, Inc. Schedules Earnings Call to Discuss First Quarter 2008 Results
8. Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006
9. Birner Dental Management Services, Inc. Declares $.17 Quarterly Dividend
10. Birner Dental Management Services, Inc. Schedules Earnings Call to Discuss Year End and Fourth Quarter 2007 Results
11. BioHorizons Announces Its 2009 Global Symposium: Bringing Together Top Thought Leaders in the Dental Implant Industry to Provide Insight on Integrating Technology into the Continuum of Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2014)... University] Much of the research on post-combat mental ... disorder (PTSD) and major depression. A paper co-authored by ... an even broader snapshot of returning soldiers, mental state ... when transitioning from soldier to civilian life and how ... published in the January issue of Society and ...
(Date:3/5/2014)... could manifest as attention deficit hyperactivity disorder in children ... by Florida State University College of Medicine researchers. , ... evidence that ADHD associated with nicotine can be passed ... be an environmentally induced health condition inherited from your ... long time ago. And the fact that you never ...
(Date:3/5/2014)... may seem normal: As we age, we misplace car ... or a meal we just ordered. But University of ... inevitable, and they,ve found a drug therapy that could ... drug can,t yet be used in humans, but the ... population of aging adults who don,t have Alzheimer,s or ...
(Date:3/4/2014)... the immune system,s ability to spot and attack ... patients with advanced melanoma, according to a multisite, ... Center and 11 other institutions. All patients had ... most had received two or more prior treatments. ... nivolumab (anti-PD-1; BMS-936558; MDX-1106; ONO-4538), survived for an ...
(Date:3/3/2014)... York University and the University of Texas at Austin ... cells. Their findings, which appear in the journal ... how these molecules may serve as signals for cancer ... to new ways in which sugars function as a ... , "Carbohydrates can tell us a lot about what,s ...
Breaking Medicine News(10 mins):Health News:Returning vets face 'warring identities' distress 2Health News:Returning vets face 'warring identities' distress 3Health News:Prenatal nicotine exposure may lead to ADHD in future generations 2Health News:Prenatal nicotine exposure may lead to ADHD in future generations 3Health News:UF researchers find drug therapy that could eventually reverse memory decline in seniors 2Health News:Investigational drug may increase survival for some patients with advanced melanoma 2Health News:Researchers identify 'carbohydrates in a coal mine' for cancer detection 2
... being transferred to cats. It has been found that cats that ... ,Scientists from Erasmus Medical Centre, Rotterdam, say the risk is being ... the H5N1 virus emerged in Thailand in 2004 when 14 out ... died. ,One had eaten a chicken carcass on a ...
... Organization must do something to draft a model law so ... African countries. ,This request was made at ... widely known that almost 80- percent of the African population ... researchers are increasingly looking to tap into this knowledge to ...
... Administration (FDA) is reconsidering and mulling over the veracity of ... link between heavy cell phone use and an increased risk ... upon an academic exercise conducted by researchers at the Swedish ... between statistics from 2,200 cancer patients and a same number ...
... being made to run , as part of the drive ... are doing whatever it takes// to create awareness of the ... a pilot programme for 12 weeks that brought into its ... turned so successful that most children not only shed the ...
... international organization which is actively working on the reduction and ... earth//. It urged the southern African governments to increase various ... this issue in mind it has launched an appeal for ... disease in Africa. ,Francoise Le Goff, regional director ...
... cannot hold our breath for a long time as oxygen is ... have recently discovered// how the Crucian Carp, a close relative of ... ,This discovery is of great interest as it helps us ... hope that this understanding of how some animals cope with a ...
Cached Medicine News:Health News:Red Cross Says Fund Boost and Awareness Are the Main Ingredients to Fight AIDS 2
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ... body fat content and preserved lean body mass ...
(Date:1/14/2014)... 2014  Luminex Corporation (Nasdaq: LMNX ) ... the fourth quarter of 2013 on Monday, February 3, ... for release after the close of trading. ... hold a conference call to discuss the operating highlights ... months ended December 31, 2013 on February 3, 2014, ...
(Date:1/14/2014)... Pa. , Jan. 14, 2014 Dynamic Healthcare ... ("GMH"), announced today that it acquired Progressive Home Medical Equipment, ... January 7, 2014. The terms of the acquisition were not ... medical equipment ("DME") company providing a wide range of sleep, ... Pennsylvania and Pittsburgh ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... GNTA ) today announced financial results and progress,for the ... recent milestones, including:, -- AGENDA ... -- New oral product, G4544, completes initial Phase 1 ... -- Tesetaxel, a leading oral taxane, becomes new clinical-stage ...
... potent DPP-4 inhibitor being developed for the ... in HbA1c in refractory ... conferring functional ... high therapeutic ...
Cached Medicine Technology:Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 2Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 3Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 4Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 5Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 6Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 7Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 8Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 9Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 10FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008 2FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008 3FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008 4FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: